Exploring Near Infrared Spectroscopy (NIRS) technologies for assessment of muscle physiology, tissue oxygenation, and blood flow in patients with Sickle Cell Disease (SCD
探索近红外光谱 (NIRS) 技术评估镰状细胞病 (SCD) 患者的肌肉生理学、组织氧合和血流
基本信息
- 批准号:10929214
- 负责人:
- 金额:$ 98.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Abnormal HemoglobinsAcuteAdoptedAffectAfrican AmericanAfrican ancestryAmino AcidsBiological MarkersBirthBlood VesselsBlood flowCardiovascular systemCerebrumChestChronicClinicalDataDevicesDiseaseEchocardiographyEnrollmentErythrocytesEthnic OriginEvaluationExerciseGlutamic AcidHemoglobinHemoglobinopathiesHemolysisHemolytic AnemiaHypoxiaImpairmentIndividualInflammationInheritedKidneyLeadLiteratureLongevityMeasurementMinority GroupsMonitorNear-Infrared SpectroscopyOpticsOrganOutcomeOutpatientsParticipantPatientsPhysiologicalPolymersProtocols documentationRecurrenceReperfusion InjuryReportingScienceShapesSickle CellSickle Cell AnemiaSiteStructureTechniquesTechnology AssessmentTestingTissuesUnited StatesValineVariantVascular DiseasesVascular EndotheliumVisitWalkingbeta Globinchronic painclinical applicationclinical centerendothelial dysfunctionhemodynamicshemoglobin AAmalignant breast neoplasmmuscle physiologypoint of careresearch studyresponsescreeningsicklingtissue oxygenationvaso-occlusive crisisvaso-occlusive pain
项目摘要
Sickle cell disease (SCD) is an inherited hemoglobinopathy that disproportionately impacts minority populations in the United States affecting about 100,000 individuals, primarily of African ancestry, and 1 in 365 African-American births. The substitution of valine by glutamic acid on the 6th amino-acid of beta globin results an abnormal hemoglobin variant (HbS) which polymerizes once deoxygenated, and alters both the structure and function of red blood cells (RBCs) distorting them into bizarre sickle shapes. Sickled RBCs have a lifespan 1/6th that of normal, resulting in chronic hemolytic anemia; they are also rigid and can obstruct microvascular blood flow causing recurring, unpredictable cycles of acute vaso-occlusive pain, commonly referred to as vaso-occlusive crises (VOC). The recurrent VOCs lead to hypoxia-reperfusion injury and together with the intravascular hemolysis promote inflammation and vascular endothelial damage. This systemic vasculopathy affects multiple organs leading to cardiovascular complications, chronic pain, cerebral and kidney impairment.
Near infrared spectroscopy (NIRS) is a non-invasive optical technique for characterizing microvascular hemodynamics including hemoglobin concentration, blood flow, and tissue oxygen saturation. There is a wealth of literature reporting on NIRS in a wide variety of clinical applications including breast cancer and exercise science. Given the impairments to microvascular flow and endothelial dysfunction associated with SCD, advanced quantitative NIRS is an attractive candidate to provide comprehensive hemodynamic evaluations in point-of-care settings. There are limited studies evaluating NIRS devices in SCD. One study has reported a relatively dampened hyperemic response after brachial cuff occlusion, indicative of endothelial dysfunction in SCD patients. The preliminary data obtained from another research study are encouraging and demonstrates that hemodynamic information collected correlates with clinical lab values.
In this single site, non-interventional, exploratory study, 40 subjects (20 SCD (HbSS and/or HbSB0) and 20 healthy controls (HbAA)) will undergo a baseline hemodynamic assessment as outpatients utilizing NIRS applications and protocols. A subset of study participants may be invited to return to the Clinical Center for clinical and NIRS reassessment periodically for a maximum of 4 additional visits, at least 3 days apart, within 120 days from their initial (baseline) visit to test for repeatability of the NIRS.
The purpose of this study is to generate further NIRS-derived tissue hemodynamic data in SCD compared to data from healthy controls. The data will help inform the most appropriate and efficient optical technique that best differentiate the abnormal hemodynamics in SCD patients from normal physiological variation in healthy controls. The optimal NIRS technique can then be adopted and applied for regular screening and disease monitoring in SCD patients. To date, There has been a total of 19 subjects enrolled (13 SCD and 6 HbAA)
镰状细胞疾病(SCD)是一种遗传性血红蛋白病,对美国影响约100,000个人,主要是非洲血统的人,而365名非裔美国人出生的人则影响少数群体。谷氨酸在β球蛋白的第六氨基酸中取代缬氨酸会导致异常的血红蛋白变体(HBS),一旦脱氧,它会聚集,并改变了红细胞(RBC)的结构和功能,使它们变成了奇怪的镰刀造型。镰状的RBC的寿命为正常的1/6,导致慢性溶血性贫血。它们也是刚性的,会阻塞微血管血流,从而导致急性血管骨髓性疼痛的反复发生,不可预测的周期,通常称为血管熟悉的危机(VOC)。复发性VOC会导致缺氧 - 再灌注损伤,并与血管内溶血一起促进炎症和血管内皮损伤。这种系统性的血管疾病会影响多个器官,导致心血管并发症,慢性疼痛,大脑和肾脏障碍。
近红外光谱(NIRS)是一种非侵入性光学技术,用于表征包括血红蛋白浓度,血流和组织氧饱和度在内的微血管血液动力学。在包括乳腺癌和运动科学在内的各种临床应用中,有大量有关NIRS的文献报道。鉴于与SCD相关的微血管流量和内皮功能障碍的损害,高级定量NIRS是在护理点环境中提供全面血液动力学评估的有吸引力的候选者。评估SCD中NIRS设备的研究有限。一项研究报道了臂袖闭塞后相对衰减的高血症反应,表明SCD患者的内皮功能障碍。从另一项研究获得的初步数据令人鼓舞,并证明收集的血液动力学信息与临床实验室值相关。
在这个单个部位,非差异,探索性研究,40名受试者(20个SCD(HBSS和/或HBSB0)和20个健康对照(HBAA)(HBAA)将接受基线血液动力学评估,利用NIRS的应用和方案,作为门诊病人。 可以邀请一部分研究参与者返回临床中心进行临床和NIRS的重新评估,最多额外4次访问,至少相隔3天,自初次(基线)访问以来,以测试NIRS的重复性。
这项研究的目的是与健康对照组的数据相比,在SCD中产生进一步的NIRS衍生的组织血流动力学数据。这些数据将有助于告知最合适,最有效的光学技术,从而最好地将SCD患者异常血液动力学与健康对照中的正常生理变异区分开。然后,可以采用最佳NIRS技术,并应用SCD患者的常规筛查和疾病监测。迄今为止,总共有19名受试者(13个SCD和6 HBAA)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Swee Lay Thein其他文献
Swee Lay Thein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Swee Lay Thein', 18)}}的其他基金
Evaluation of the safety, tolerability, pharmacokinetics, and pharmacodynamics of long-term mitapivat dosing in subjects with stable sickle cell disease
稳定型镰状细胞病受试者长期服用 mitapivat 的安全性、耐受性、药代动力学和药效学评估
- 批准号:
10699750 - 财政年份:
- 资助金额:
$ 98.68万 - 项目类别:
Evaluation of the safety, tolerability, pharmacokinetics, and pharmacodynamics of long-term mitapivat dosing in subjects with stable sickle cell disease
稳定型镰状细胞病受试者长期服用 mitapivat 的安全性、耐受性、药代动力学和药效学评价
- 批准号:
10929203 - 财政年份:
- 资助金额:
$ 98.68万 - 项目类别:
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease
一项初步研究,旨在评估稳定型镰状细胞病受试者多次口服 AG-348 剂量的安全性、耐受性、药代动力学和药效学
- 批准号:
10699741 - 财政年份:
- 资助金额:
$ 98.68万 - 项目类别:
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease
一项初步研究,旨在评估稳定型镰状细胞病受试者多次口服 AG-348 剂量的安全性、耐受性、药代动力学和药效学
- 批准号:
10929187 - 财政年份:
- 资助金额:
$ 98.68万 - 项目类别:
Genotype -Phenotype Correlation of PKLR Variants with Pyruvate Kinase, 2,3-Diphosphglycerate and ATP Activities in Red Blood Cells of Patients with Sickle Cell Disease
镰状细胞病患者红细胞中 PKLR 变异体与丙酮酸激酶、2,3-二磷酸甘油酸和 ATP 活性的基因型-表型相关性
- 批准号:
10262682 - 财政年份:
- 资助金额:
$ 98.68万 - 项目类别:
Genotype -Phenotype Correlation of PKLR Variants with Pyruvate Kinase, 2,3-Diphosphglycerate and ATP Activities in Red Blood Cells of Patients with Sickle Cell Disease
镰状细胞病患者红细胞中 PKLR 变异体与丙酮酸激酶、2,3-二磷酸甘油酸和 ATP 活性的基因型-表型相关性
- 批准号:
10699742 - 财政年份:
- 资助金额:
$ 98.68万 - 项目类别:
Studies of the Natural History of Sickle Cell Disease
镰状细胞病自然史的研究
- 批准号:
10929182 - 财政年份:
- 资助金额:
$ 98.68万 - 项目类别:
Studies of the Natural History of Sickle Cell Disease
镰状细胞病自然史的研究
- 批准号:
10253904 - 财政年份:
- 资助金额:
$ 98.68万 - 项目类别:
Genotype -Phenotype Correlation of PKLR Variants with Pyruvate Kinase, 2,3-Diphosphglycerate and ATP Activities in Red Blood Cells of Patients with Sickle Cell Disease
镰状细胞病患者红细胞中 PKLR 变异体与丙酮酸激酶、2,3-二磷酸甘油酸和 ATP 活性的基因型-表型相关性
- 批准号:
10929188 - 财政年份:
- 资助金额:
$ 98.68万 - 项目类别:
Studies of the Natural History of Sickle Cell Disease
镰状细胞病自然史的研究
- 批准号:
10699739 - 财政年份:
- 资助金额:
$ 98.68万 - 项目类别:
相似国自然基金
用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
- 批准号:32301097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
- 批准号:82300739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
- 批准号:82302221
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Innate Immune Response in Cardiac Healing and Rejuvenation
心脏愈合和恢复活力中的先天免疫反应
- 批准号:
10625955 - 财政年份:2023
- 资助金额:
$ 98.68万 - 项目类别:
Commercial translation of high-density carbon fiber electrode arrays for multi-modal analysis of neural microcircuits
用于神经微电路多模态分析的高密度碳纤维电极阵列的商业转化
- 批准号:
10761217 - 财政年份:2023
- 资助金额:
$ 98.68万 - 项目类别:
Annual wellness visit policy: Impact on disparities in early dementia diagnosis and quality of healthcare for Medicare beneficiaries with Alzheimer's Disease and Its Related Dementias
年度健康就诊政策:对患有阿尔茨海默病及其相关痴呆症的医疗保险受益人的早期痴呆诊断和医疗质量差异的影响
- 批准号:
10729272 - 财政年份:2023
- 资助金额:
$ 98.68万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 98.68万 - 项目类别: